are there any downsides to glp 1 The of GLP-1 Weight-Loss Drugs and Smarter, Sustainable Alternatives** 🔖 Read Article. link in bio @muscleandfitness @linear_bar Rx Trends: Real-World Data on

GLP-1RAs reduce the pro-inflammatory aspects of cerebral atherosclerosis by lowering oxidative stress, apoptosis and the production and build-up of advanced glycation end products at the molecular and cellular levels

Januvia is not for patients with type 1 diabetes

The muscle loss problem explained GLP-1 agonist weight loss typically includes significant lean mass reduction

The Sp treated cells recovered completely from stress induced cell death observed in case of 3-AT (Fig

This article shows the effect of semaglutide 2.4 mg on cardiovascular outcomes in people with overweight or obesity without T2D

Some new data came in on June 8: Lilly reported Foundayo beat oral semaglutide head-to-head in type 2 diabetes (ACHIEVE-3): 9.2% weight loss and 2.2% A1C reduction at 17.2 mg vs 5.3% / 1.4% for oral sema